Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10728691 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
Condition: Cancer
Interventions: Drug: celecoxib;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiation Therapy

Indicates status has not been verified in more than two years